AIM: To systematically assess the efficacy and safety of β-adrenergic blocker plus 5-isosorbide mononitrate (BB + ISMN) and endoscopic band ligation (EBL) on prophylaxis of esophageal variceal rebleeding. METHODS: Ra...AIM: To systematically assess the efficacy and safety of β-adrenergic blocker plus 5-isosorbide mononitrate (BB + ISMN) and endoscopic band ligation (EBL) on prophylaxis of esophageal variceal rebleeding. METHODS: Randomized controlled trials (RCTs) comparing the efficacy and safety of BB + ISMN and EBL on prophylaxis of esophageal variceal rebleeding were gathered from Medline, Embase, Cochrane Controlled Trial Registry and China Biological Medicine database between January 1980 and August 2007. Data from five trials were extracted and pooled. The analyses of the available data using the Revman 4.2 software were based on the intention-to-treat principle. RESULTS: Four RCTs met the inclusion criteria. In comparison with BB + ISMN with EBL in prophylaxis of esophageal variceal rebleeding, there was no significant difference in the rate of rebleeding [relative risk (RR), 0.79; 95% CI: 0.62-1.00; P = 0.05], bleeding-related mortality (RR, 0.76; 95% CI: 0.31-1.42; P = 0.40), overall mortality (RR, 0.81; 95% CI: 0.61-1.08; P = 0.15) and complications (RR, 1.26; 95% CI: 0.93-1.70; P = 0.13). CONCLUSION:In the prevention of esophageal variceal rebleeding, BB + ISMN are as effective as EBL. There are few complications with the two treatment modalities. Both BB + ISMN and EBL would be considered as the first-line therapy in the prevention of esophageal variceal rebleeding.展开更多
High molecular weight poly(1,4-butylene 2,5-furandicarboxylate-co-isosorbide 2,5-furandicarboxylate)copolyesters(PBSIF-x)were synthesized via melt-polycondensation of 2,5-furandicarboxylic acid(FDCA),with varying rati...High molecular weight poly(1,4-butylene 2,5-furandicarboxylate-co-isosorbide 2,5-furandicarboxylate)copolyesters(PBSIF-x)were synthesized via melt-polycondensation of 2,5-furandicarboxylic acid(FDCA),with varying ratios of isosorbide(ISB)and 1,4-butylene glycol(BDO)catalyzed by antimony trioxide(Sb_(2)O_(3)).The PBSIF-x structures were investigated using FTIR and~1H NMR,while the GPC analysis exhibited the copolyesters molecular weights with number average molecular mass(M_n)in the range of 11079-15153 g/mol.The DSC results show that PBSIF-x copolyesters have a single glass-transition temperature(T_(g))(77.45-110.96℃),increasing with the increase in ISB content,while TGA analysis demonstrates excellent thermal stability up to 320℃.From the thermal result,properties of PBSIF-x copolyesters are found to be within the interval of their parent homologues poly(butylene 2,5-furandicarboxylate)(PBF)and poly(isosorbide 2,5-furandicarboxylate)(PIF),which confirms the aromatic/aliphatic blending within the polymer matrix for enhanced polymer stability and performance.展开更多
文摘AIM: To systematically assess the efficacy and safety of β-adrenergic blocker plus 5-isosorbide mononitrate (BB + ISMN) and endoscopic band ligation (EBL) on prophylaxis of esophageal variceal rebleeding. METHODS: Randomized controlled trials (RCTs) comparing the efficacy and safety of BB + ISMN and EBL on prophylaxis of esophageal variceal rebleeding were gathered from Medline, Embase, Cochrane Controlled Trial Registry and China Biological Medicine database between January 1980 and August 2007. Data from five trials were extracted and pooled. The analyses of the available data using the Revman 4.2 software were based on the intention-to-treat principle. RESULTS: Four RCTs met the inclusion criteria. In comparison with BB + ISMN with EBL in prophylaxis of esophageal variceal rebleeding, there was no significant difference in the rate of rebleeding [relative risk (RR), 0.79; 95% CI: 0.62-1.00; P = 0.05], bleeding-related mortality (RR, 0.76; 95% CI: 0.31-1.42; P = 0.40), overall mortality (RR, 0.81; 95% CI: 0.61-1.08; P = 0.15) and complications (RR, 1.26; 95% CI: 0.93-1.70; P = 0.13). CONCLUSION:In the prevention of esophageal variceal rebleeding, BB + ISMN are as effective as EBL. There are few complications with the two treatment modalities. Both BB + ISMN and EBL would be considered as the first-line therapy in the prevention of esophageal variceal rebleeding.
基金Funded by the Program(BG2021)of High-end Foreign Experts of The State Administration of Foreign Experts Affairs(SAFEA)the Young Talent Project of Hubei Provincial Department of Education,China(No.Q20201108)。
文摘High molecular weight poly(1,4-butylene 2,5-furandicarboxylate-co-isosorbide 2,5-furandicarboxylate)copolyesters(PBSIF-x)were synthesized via melt-polycondensation of 2,5-furandicarboxylic acid(FDCA),with varying ratios of isosorbide(ISB)and 1,4-butylene glycol(BDO)catalyzed by antimony trioxide(Sb_(2)O_(3)).The PBSIF-x structures were investigated using FTIR and~1H NMR,while the GPC analysis exhibited the copolyesters molecular weights with number average molecular mass(M_n)in the range of 11079-15153 g/mol.The DSC results show that PBSIF-x copolyesters have a single glass-transition temperature(T_(g))(77.45-110.96℃),increasing with the increase in ISB content,while TGA analysis demonstrates excellent thermal stability up to 320℃.From the thermal result,properties of PBSIF-x copolyesters are found to be within the interval of their parent homologues poly(butylene 2,5-furandicarboxylate)(PBF)and poly(isosorbide 2,5-furandicarboxylate)(PIF),which confirms the aromatic/aliphatic blending within the polymer matrix for enhanced polymer stability and performance.
